Morphotek / Bayer / CCR’s Laboratory / Aduro Biotech Inc. / Pastan / Hassan / Bayer AG / /
Country
United States / /
Event
FDA Phase / Judicial Event / Company Expansion / Business Partnership / /
Facility
Sarah Cannon Research Institute / Wake Forest Baptist Medical Center’s Comprehensive Cancer Center / NIH Clinical Center / University of Texas M.D. Anderson Cancer Center / CCR’s Laboratory of Molecular Biology / Pastan’s laboratory / /
IndustryTerm
cancer therapy / cancer therapeutics / cancer treatment / /
MedicalCondition
mesothelioma studies / N.C. While studying ovarian cancer / advanced disease / ovarian cancer / mesothelin-expressing cancer / mesothelioma population / largest mesothelioma clinics / bronchitis / solid tumors / different leukemias / mesothelioma / mesothelioma clinic / tumor’s / mesothelinpositive tumors / back pain / cancers / tumor / pleural and peritoneal mesothelioma / pneumonia / cancer / tumors / disease / shortness of breath / blood cancers / pleural mesothelioma / advanced solid tumors / pancreatic cancers / mesothelin-directed cancer / targeted cancer / selective cancer / mesothelin-expressing tumors / infection / cough / /
MedicalTreatment
chemotherapy / Surgery / cancer therapy / cancer therapeutics / cell therapy / CCR / /
Organization
National Institute of Health / Sarah Cannon Research Institute / NIH Clinical Center / University of Texas M.D. Anderson Cancer Center in Houston / Mesothelioma Applied Research Foundation / Wake Forest Baptist Medical Center’s Comprehensive Cancer Center / /
Person
Lisa Bengtson / Mary Hesdorffer / Raffit Hassan / Jeannette Nashed / Ira Pastan / Daniel Fowler / Roy Lescalleet / Robert Kreitman / Partha Chowdhury / Neetu Kalra / Steven Rosenberg / Yvonne Mallory / Mark Willingham / Kristi Lescalleet / Andrew Miller / Sarah Cannon / /
Position
Investigator / Executive Director / Principal Investigator / Co-Chief / Chief / pilot / Research Biologist NCI / R.N. / /
f e a t u r e Precision in Targeting with Anti-Mesothelin Therapies For two decades, Raffit Hassan, M.D., Co-Chief of CCR’s Thoracic and Gastrointestinal Oncology